Search

Author/Creator van Wetering, Sandra

1. Allogeneic dendritic cell (DC) vaccination as an "off the shelf" treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study. (7th November 2013)

Authors:
de Gruijl, Tanja; Santegoeds, Saskia; van Wetering, Sandra; Singh, Satwinder Kaur; Hall, Anthony; van de Loosdrecht, Arjan A; Kruisbeek, Ada
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma. Issue 9 (November 2017)

Authors:
Leaf, Rebecca Karp; Stroopinsky, Dina; Pyzer, Athalia R.; Kruisbeek, Ada M.; van Wetering, Sandra; Washington, Abigail; Ephraim, Adam; Cole, Leandra; Morin, Adam; Jain, Salvia; Nahas, Myrna R.; Apel, Arik; Arnason, Jon; Hamdan, Ayad; Rosenblatt, Jacalyn; Avigan, David
Journal:
Journal of immunotherapy
Issue:
Volume 40:Issue 9(2017:Nov./Dec.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Procedures for the expansion of CD14+ precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapy. (November 2013)

Authors:
van den Ancker, Willemijn; Wijnands, Pepijn GJB; Ruben, Jurjen M; Westers, Theresia M; Punt, Bianca; Bachas, Costa; Ravenshorst, Niek; van Wetering, Sandra; Kruisbeek, Ada M; Bontkes, Hetty J; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; de Gruijl, Tanja D
Journal:
Immunotherapy
Issue:
Volume 5:Number 11(2013:Nov.)
Page Start:
1183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗